Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05838508

Effect of Physical Activity Pattern on Cardiometabolic Health

The goal of this study is to understand the interaction between the circadian system and physical activity.

Participants will:

* complete 2 inpatient stays * perform moderate exercise * be provided with identical meals * have frequent blood draws * provide urine and saliva samples

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location status: Recruiting

Location contact

Frank Scheer, PhD

SUB_INVESTIGATOR

Jingyi Qian, PhD

CONTACT

[email protected]

6175257423

Jingyi Qian, PhD

PRINCIPAL_INVESTIGATOR

Vy Nguyen, B.S.

CONTACT

[email protected]

617-525-0662

About this study

The endogenous circadian system (i.e., an internal biological rhythm) plays an important role in regulating blood glucose, blood pressure, and energy expenditure. Physical activity improves health and reduces the risk for cardiovascular diseases and type 2 diabetes. The goal of this study is to understand the interaction between the circadian system and physical activity. We aim to test whether such relationship between the circadian system and physical activity can be used to enhance the health benefits of physical activity.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-45 yr old
  • Body mass index (BMI) 18.5 - 34.9 kg/m2
  • No acute, chronic or debilitating medical conditions (e.g. metabolic, cardiovascular, respiratory, neurological, cancers, etc.)
  • Willing to adhere to the protocol requirements for the duration of the study

Exclusion criteria

  • Currently smoking/vaping or 5 or more years of smoking/vaping
  • Currently pregnant or breastfeeding
  • History of drug or alcohol dependency
  • History of psychiatric illness or disorder
  • Any hospitalization due to COVID-19
  • Inability to exercise for any reason
  • Any known contraindication to exercise testing based on current ACSM guidelines

Treatment and study plan

Exercise Intervention

Behavioral

Research participants will be assigned to two exercise conditions.

Primary outcomes

  1. glucose level

    Time frame: 24-hour test period after exercise

    mean glucose level after exercise session

  2. mean arterial pressure

    Time frame: 24-hour test period after exercise

    mean arterial pressure after exercise session

Secondary outcomes

  1. insulin sensitivity index

    Time frame: about 12 and 24 hours after exercise

    Oral Minimal Model method estimates mean insulin sensitivity based on blood glucose and insulin levels from two mixed meal tests after exercise session

  2. beta-cell function index

    Time frame: about 12 and 24 hours after exercise

    Oral Minimal Model method estimates mean beta-cell function based on blood glucose, insulin and c-peptide levels from two mixed meal tests after exercise session

  3. total peripheral resistance

    Time frame: 24-hour test period after exercise

    total peripheral resistance derived from BP waveform measured by finger plethysmography

  4. autonomic nervous system activity

    Time frame: 24-hour test period after exercise

    derived by time-domain heart rate variability analysis

Other outcomes

  1. resting energy expenditure

    Time frame: 24-hour test period after exercise

    energy expenditure will be measured at 1-2 hours interval by indirect calorimetry

  2. respiratory exchange ratio

    Time frame: 24-hour test period after exercise

    respiratory exchange ratio will be measured at 1-2 hours interval by indirect calorimetry

Study contacts

Contact information is provided by the study sponsor or research team.

Jingyi Qian, PhD

CONTACT

[email protected]

6175257423

Vy Nguyen, B.S.

CONTACT

[email protected]

617-525-0662

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Acronym: PACE

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 1, 2023
Registry last updated
Jun 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.